Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Hepatitis B vaccine-Tel-Aviv Sourasky Medical Center
- Development stage
- Preclinical
- Lead developer
- Tel Aviv Sourasky Medical Center
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
Hepatitis B vaccine-Tel-Aviv Sourasky Medical Center refers to a Hepatitis B vaccine utilized in clinical research at the Tel-Aviv Sourasky Medical Center to investigate the relationship between the mesolimbic reward system and immune functioning. In this context, the vaccine serves as a biological probe to assess how neuromodulation, specifically via fMRI neurofeedback, can influence the human immune response. Standard Hepatitis B vaccines are typically composed of recombinant Hepatitis B surface antigen (HBsAg), which stimulates the production of protective antibodies (anti-HBs) to provide active immunity against the Hepatitis B virus (HBV). The research at Sourasky Medical Center specifically monitors the antibody titers following vaccination as a quantitative measure of immune system efficacy in response to behavioral interventions.
- Other names
- Hepatitis B vaccinationHepatitis B vaccine
02
Targets
HBsAg (Hepatitis B surface antigen)
Beyond the preview
Go deeper on Hepatitis B vaccine-Tel-Aviv Sourasky Medical Center.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Hepatitis B vaccine-Tel-Aviv Sourasky Medical Center.